Q/C Technologies, Inc. Preferred Stock Dividends and Other Adjustments
Q/C Technologies, Inc. (QCLS) reported Preferred Stock Dividends and Other Adjustments of -$76.72 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2026-08-12
- Q/C Technologies, Inc. preferred stock dividends and other adjustments for the quarter ending 2026-06-30 was -$76.72K, a 107.86% decline year-over-year.
- Q/C Technologies, Inc. preferred stock dividends and other adjustments for the quarter ending 2026-03-31 was $285.67K, a 64.88% decline year-over-year.
- Q/C Technologies, Inc. preferred stock dividends and other adjustments for the quarter ending 2025-12-31 was $665.56K, a 37.89% decline year-over-year.
- Q/C Technologies, Inc. preferred stock dividends and other adjustments for the quarter ending 2025-09-30 was $901.90K, a 20.09% increase year-over-year.
- Q/C Technologies, Inc. preferred stock dividends and other adjustments for fiscal 2025 was $3.36M, a 11.69% decline from fiscal 2024.
- Q/C Technologies, Inc. preferred stock dividends and other adjustments for fiscal 2024 was $3.80M, a 9.87% decline from fiscal 2023.
- Q/C Technologies, Inc. preferred stock dividends and other adjustments for fiscal 2023 was $4.22M.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$76.72K 10-Q · filed 2026-08-12 | $208.96K 10-Q · filed 2026-08-12 | $874.51K derived: sum of 3 quarters · filed 2026-08-12 | $1.78M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $285.67K 10-Q · filed 2026-05-15 | $951.23K derived: sum of 2 quarters · filed 2026-05-15 | $1.85M derived: sum of 3 quarters · filed 2026-05-15 | $2.83M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $665.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.57M derived: sum of 2 quarters · filed 2026-04-15 | $2.54M derived: sum of 3 quarters · filed 2026-08-12 | $3.36M 10-K · filed 2026-04-15 |
| 2025-09-30 | $901.90K 10-Q · filed 2025-11-19 | $1.88M derived: sum of 2 quarters · filed 2026-08-12 | $2.69M 10-Q · filed 2025-11-19 | $3.76M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $976.37K 10-Q · filed 2026-08-12 | $1.79M 10-Q · filed 2026-08-12 | $2.86M derived: sum of 3 quarters · filed 2026-08-12 | $3.61M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $813.50K 10-Q · filed 2026-05-15 | $1.89M derived: sum of 2 quarters · filed 2026-05-15 | $2.64M derived: sum of 3 quarters · filed 2026-05-15 | $3.41M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.82M derived: sum of 2 quarters · filed 2026-04-15 | $2.60M derived: sum of 3 quarters · filed 2026-04-15 | $3.80M 10-K · filed 2026-04-15 |
| 2024-09-30 | $751.05K 10-Q · filed 2025-11-19 | $1.53M derived: sum of 2 quarters · filed 2025-11-19 | $2.73M 10-Q · filed 2025-11-19 | $5.26M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $777.34K 10-Q · filed 2025-08-19 | $1.98M 10-Q · filed 2025-08-19 | $4.51M derived: sum of 3 quarters · filed 2025-08-19 | $5.67M derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $1.20M 10-Q · filed 2025-05-15 | $3.73M derived: sum of 2 quarters · filed 2025-05-15 | $4.89M derived: sum of 3 quarters · filed 2025-05-15 | $5.26M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-11 | $3.69M derived: sum of 2 quarters · filed 2025-04-11 | $4.06M derived: sum of 3 quarters · filed 2025-04-11 | $4.22M 10-K · filed 2025-04-11 |
| 2023-09-30 | $1.16M 10-Q · filed 2024-11-14 | $1.53M derived: sum of 2 quarters · filed 2024-11-14 | $1.69M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $373.80K 10-Q · filed 2024-08-19 | $532.13K 10-Q · filed 2024-08-19 | ||
| 2023-03-31 | $158.33K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |